Phibro Animal Health | PAHC - Operating Profit


Phibro Animal Health reported $54.99M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Align Technology USD 178.05M 46.66M Mar/2026
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Eli Lilly USD 9.78B 792M Mar/2026
Henry Schein USD 182M 4M Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD -1.88B 8.12B Mar/2026
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Pacira USD 4.62M 1.43M Mar/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 75.49M 7M Mar/2026
Supernus Pharmaceuticals USD -35.25M 49.07M Mar/2026
Zoetis USD 865M 30M Mar/2026